ZBH

#615
Zimmer Biomet Holdings, Inc.
96.5400 USD
+1.89%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
96.2200
96.6400
Jahresspanne
84.5900
103.6900
Tagesänderung
+1.89%
Monatliche Änderung
+2.70%
6 month change
-6.72%
Jahresänderung
-6.72%
Vorheriger Schlusskurs
94.7450
Eröffnung
96.3800
Bid
Ask
Tief
96.2200
High
96.6400
Volumen
1 121
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 18.8882 B
  • Employee 17 K
  • Founded N/A
  • CEO Ivan Tornos
  • Website www.zimmerbiomet.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKPL53
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
25.33
Preis-Umsatz-Verhältnis
2.25
Dividende je Aktie
0.96
Dividendenrendite in %
1.07

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.

Nachrichten